| scholarly article | Q13442814 |
| P50 | author | Marc Peters-Golden | Q82192734 |
| P2093 | author name string | Bethany B Moore | |
| Carol A Wilke | |||
| Galen B Toews | |||
| Kevin M Vannella | |||
| Tracy R McMillan | |||
| Peedikayil E Thomas | |||
| Ryan P Charbeneau | |||
| P2860 | cites work | Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis | Q37354132 |
| Pharmacological inhibition of leukotrienes in an animal model of bleomycin-induced acute lung injury | Q40324025 | ||
| Effector mechanisms of intestinally induced immunity to Pseudomonas aeruginosa in the rat lung: role of neutrophils and leukotriene B4 | Q40374025 | ||
| Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases | Q40773752 | ||
| Cellular and in vitro transport of glutathione conjugates by MRP. | Q41199381 | ||
| Modulation of fibroblast proliferation by sulfidopeptide leukotrienes: effect of indomethacin | Q41369510 | ||
| Neutrophil Chemotactic Factors in the Respiratory Tract of Patients with Chronic Airway Diseases or Idiopathic Pulmonary Fibrosis | Q42060725 | ||
| The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. | Q42105688 | ||
| Protection from pulmonary fibrosis in the absence of CCR2 signaling | Q43760123 | ||
| Protection from pulmonary fibrosis in leukotriene-deficient mice | Q43854271 | ||
| Leukotriene B4 Induces In Vitro Fibroblast Chemotaxis | Q43871023 | ||
| The role of monocyte chemotactic protein-1 (MCP-1) in the recruitment of monocytes and CD4+ T cells during a pulmonary Cryptococcus neoformans infection | Q43967446 | ||
| A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis | Q43976649 | ||
| In vitro sensitization of human bronchus by beta2-adrenergic agonists | Q44176962 | ||
| Targeted gene disruption reveals the role of the cysteinyl leukotriene 2 receptor in increased vascular permeability and in bleomycin-induced pulmonary fibrosis in mice | Q45029761 | ||
| Peroxisome proliferator-activated receptor and farnesoid X receptor ligands differentially regulate sebaceous differentiation in human sebaceous gland organ cultures in vitro | Q45112437 | ||
| Human alveolar macrophage inhibition of lung fibroblast growth. A prostaglandin-dependent process | Q50233076 | ||
| Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. | Q52512619 | ||
| Binding of leukotriene C4 to rat lung fibroblasts and stimulation of collagen synthesis in vitro | Q69833858 | ||
| Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells | Q73800249 | ||
| Peripheral blood fibrocytes: differentiation pathway and migration to wound sites | Q73966720 | ||
| Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes | Q74463702 | ||
| Cysteinyl leukotriene receptors | Q78517576 | ||
| Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice | Q80070088 | ||
| Inhibition by methylprednisolone of zymosan-induced leukotriene synthesis in alveolar macrophages | Q93536217 | ||
| Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease | Q30442380 | ||
| Real-time quantitative RT-PCR after laser-assisted cell picking | Q31978191 | ||
| PGE(2) inhibition of TGF-beta1-induced myofibroblast differentiation is Smad-independent but involves cell shape and adhesion-dependent signaling | Q33756992 | ||
| Peripheral blood fibrocytes: mesenchymal precursor cells and the pathogenesis of fibrosis | Q34109152 | ||
| Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma | Q34207374 | ||
| Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. | Q34211740 | ||
| CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury | Q34399563 | ||
| Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators | Q34525796 | ||
| Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics | Q34633590 | ||
| Human bronchial fibroblasts express the 5-lipoxygenase pathway | Q34997664 | ||
| Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair | Q36437461 | ||
| Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis | Q36849123 | ||
| Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis | Q36853612 | ||
| Mononuclear cell modulation of connective tissue function: suppression of fibroblast growth by stimulation of endogenous prostaglandin production | Q37020888 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 7883-7890 | |
| P577 | publication date | 2007-12-01 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function | |
| P478 | volume | 179 |
| Q39042181 | 5-Lipoxygenase and cysteinyl leukotriene receptor 1 regulate epidermal growth factor-induced cell migration through Tiam1 upregulation and Rac1 activation. |
| Q37697795 | 5-Lipoxygenase inhibitors: a review of recent developments and patents |
| Q96128937 | Alveolar lipids in pulmonary disease. A review |
| Q31053453 | Angiotensin-(1-7) suppresses the number and function of the circulating fibrocytes by upregulating endothelial nitric oxide synthase expression |
| Q35395038 | Biphasic presence of fibrocytes in a porcine hypertrophic scar model |
| Q54419471 | Blockade of cysteinyl leukotriene-1 receptors suppresses airway remodelling in mice overexpressing GATA-3. |
| Q38917825 | Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes. |
| Q34250211 | Decreased fibrocyte number is associated with atherosclerotic plaque instability in man. |
| Q90574419 | Depletion of Bone Marrow-Derived Fibrocytes Attenuates TAA-Induced Liver Fibrosis in Mice |
| Q28387716 | Direct isolation of myofibroblasts and fibroblasts from bleomycin-injured lungs reveals their functional similarities and differences |
| Q42969093 | Dual inhibition of wound healing and oxidative process by montelukast in experimental colon anastomoses |
| Q43000096 | Effect of leukotriene D4 on mouse embryonic stem cell migration and proliferation: involvement of PI3K/Akt as well as GSK-3β/β-catenin signaling pathways |
| Q36970702 | Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time? |
| Q37208991 | Expanding roles for leukotrienes in airway inflammation |
| Q36232242 | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation |
| Q30435304 | Fibrocyte CXCR4 regulation as a therapeutic target in pulmonary fibrosis |
| Q36690680 | Fibrocytes: emerging effector cells in chronic inflammation |
| Q38206104 | Fibrosis--a lethal component of systemic sclerosis |
| Q33799756 | Following the path of CCL2 from prostaglandins to periostin in lung fibrosis |
| Q28388821 | Genetically manipulated mouse models of lung disease: potential and pitfalls |
| Q39079208 | IL-33 enhanced the proliferation and constitutive production of IL-13 and IL-5 by fibrocytes |
| Q36718129 | Implicating exudate macrophages and Ly-6C(high) monocytes in CCR2-dependent lung fibrosis following gene-targeted alveolar injury |
| Q41904647 | Improved serum-free culture conditions for the differentiation of human and murine fibrocytes. |
| Q33942836 | Inhibitory effect of CXC chemokine receptor 4 antagonist AMD3100 on bleomycin induced murine pulmonary fibrosis |
| Q43055697 | Involvement of leukotrienes in the pathogenesis of silica-induced pulmonary fibrosis in mice |
| Q39342306 | Latent herpesvirus infection augments experimental pulmonary fibrosis |
| Q46011006 | Leukotriene C4 aggravates bleomycin-induced pulmonary fibrosis in mice. |
| Q35106124 | Leukotrienes and airway inflammation |
| Q38180825 | Paracrine functions of fibrocytes to promote lung fibrosis |
| Q50734440 | Predicting adverse drug reaction profiles by integrating protein interaction networks with drug structures. |
| Q35219865 | Prostaglandin E2 and the pathogenesis of pulmonary fibrosis. |
| Q41432422 | Role of the Cysteinyl Leukotrienes in the Pathogenesis and Progression of Cardiovascular Diseases |
| Q30486086 | Stem cells and cell therapies in lung biology and lung diseases |
| Q84303950 | Stem cells and cell therapies in lung biology and lung diseases |
| Q29346986 | Sustained hypoxia promotes the development of a pulmonary artery-specific chronic inflammatory microenvironment |
| Q30433418 | The role of fibrocytes in fibrotic diseases of the lungs and heart |
| Q34408050 | Toll-like receptor 2 agonists inhibit human fibrocyte differentiation |
| Q36164138 | Transforming growth factor β1-induced astrocyte migration is mediated in part by activating 5-lipoxygenase and cysteinyl leukotriene receptor 1. |
| Q37815487 | Viral infection and aging as cofactors for the development of pulmonary fibrosis |
| Q34001662 | γ-Herpes virus-68, but not Pseudomonas aeruginosa or influenza A (H1N1), exacerbates established murine lung fibrosis |
Search more.